Results 111 to 120 of about 15,404 (212)
Asymmetric synthesis of (-)-(R)-sitagliptin
The asymmetric synthesis of (-)-(R)-sitagliptin was achieved in seven steps from commercially available starting materials using the highly diastereoselective conjugate additions of either lithium (R)-N-benzyl-N- (α-methylbenzyl)amide or lithium (R)-N ...
Paul M. Roberts +12 more
core +1 more source
Sitagliptin induced acute severe nasopharyngitis
Acute nasopharyngitis is one of the distressing adverse effects seen with the use of dipeptidyl peptidase-4 inhibitors like sitagliptin.
Krishnan, V., Rai, Shivali
core
Comparative effectiveness of sitagliptin vs sulphonylureas in older people [PDF]
BACKGROUND: two common anti-diabetic treatments used are sitagliptin and sulphonylureas however evidence examining their comparative effectiveness in older people is limited.
Sharma, M, Petersen, I, Nazareth, I
core
Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin.
peer reviewedIMPORTANCE OF THE FIELD: Type 2 diabetes is an increasingly prevalent disease resulting from various complex combinations of defects in insulin secretion and insulin action.
Scheen, André, André J Scheen
core +1 more source
Highly Efficient Asymmetric Synthesis of Sitagliptin
A highly efficient synthesis of sitagliptin, a potent and selective DPP-4 inhibitor for the treatment of type 2 diabetes mellitus (T2DM), has been developed.
Yi Hsiao (771103) +15 more
core +1 more source
Electrochemical Synthesis of a Sitagliptin Precursor
A novel synthesis of sitagliptin based on a redox-active ester derived from the chiral pool is reported. The key step is an electrochemical nickel-catalyzed sp2-sp3 cross-coupling reaction using inexpensive nickel foam in an undivided cell.
Elisabeth K. Oehl (18435523) +6 more
core +1 more source
Introduction: The present study evaluated the bioequivalence of a fixed-dose combination (FDC) of sitagliptin and glimepiride with the originator reference product.
Prashant Kumthekar +4 more
doaj +1 more source
(B) Quantification of β-cell mass in the pancreases of non-diabetic control mice and diabetic mice with restored normoglycemia after 7 weeks of treatment with PSN632408, sitagliptin, or PSN632408 and sitagliptin combination (3 to 4 mice per group).
Ansarullah (286218) +5 more
core +1 more source
Type 2 diabetes is a complex disease that is typically diagnosed in midlife and is characterized by progressive defects in insulin secretion and action.
AL-Shukri, Deleen Abd-AL Wahab +1 more
core
Noncardiac pulmonary edema induced by sitagliptin treatment
A 74-year-old male patient with type 2 diabetes mellitus admitted to the emergency department with the complaints of progressive breathlessness, dry cough, and swollen lower extremities.
Suleyman Yuce +4 more
core +1 more source

